Atlas Trials

Intranasal Ketamine for Late-Life Depression and Suicidal Ideation

Clinical trial NCT02295787 · WITHDRAWN

Trial details

NCT number
NCT02295787
Sponsor
Massachusetts General Hospital
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
DepressionSuicideSuicidal Ideation
Start date
2015-07-01
Primary completion
2015-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.